SBIR-STTR Award

Natural Adjuvants to Enhance Efficacy of Anti-Viral Vaccines for Mariculture
Award last edited on: 6/19/2018

Sponsored Program
SBIR
Awarding Agency
DOC : NOAA
Total Award Amount
$391,143
Award Phase
2
Solicitation Topic Code
8.1.2
Principal Investigator
David B Powell

Company Information

ProFISHent Inc

17806 NE 26th Street
Redmond, WA 98052
   (425) 883-9896
   davidp@profishent.com
   www.profishent.com
Location: Single
Congr. District: 01
County: King

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2010
Phase I Amount
$92,716
Viral diseases are a major impediment to the development and expansion of environmentally safe and sustainable aquaculture systems (NMFS 2007). Despite control measures, pathogenic viruses kill millions of fish and shellfish every year (ICES Mariculture Committee 2004). To date, vaccines against fish viruses have generally provided extremely poor protection or are too expensive (e.g. DNA vaccines). We will test the feasibility of binding natural marine and terrestrial biological structures to viruses to boost the immunogenicity of viral antigens delivered to the gills and mucosal surfaces of aquatic animals. A nanotechnology-based dynamic light scattering laser instrument will verify the attachment of the model virus particles. Groups of Atlantic Salmon (Salmo salar) will then undergo needle-less, immersion immunization with the most promising vaccine formulations to assess safety and efficacy. Antibody titers will be compared to identify candidate vaccine adjuvant systems for further investigations planned in Phase II research. SUMMARY OF

Anticipated Results:
We anticipate that this new platform technology will provide an economical, nontoxic, "micro-attachment" vaccine delivery system for enhanced infectious disease prevention and control. If successful, these treatments will promote an increased choice of cultured species, greater predictability of production for investment, and the growth of environmentally sustainable aquaculture systems which will help the United Stated reduce seafood trade deficits (Nash 2004)

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
2011
Phase II Amount
$298,427
Marine aquaculture production now exceeds 20 million metric tons annually (FAO 2010) but viral diseases are still a major threat to the expansion of sustainable mariculture systems (National Marine Fisheries Service 2007). Pathogenic viruses continue to devastate many fish and shellfish operations every year (ICES Mariculture Committee 2004, Lightner 2011). To date, vaccines against aquatic animal viruses have generally provided poor protection, are too expensive, and/or must be injected intramuscularly (e.g., DNA vaccines). In response, we will expand and intensify development of innovative biological adjuvant systems initiated in our Phase I trials. We discovered that unique natural marine and terrestrial micro-structures bound to viral antigens can be delivered to gills and mucosal surfaces of salmon to boost specific immune responses against a viral pathogen. We use a nanotechnology-based dynamic light scattering laser instrument to verify attachment of viral antigens or DNA vaccines. Interferon-associated genes and specific antibody titers will be measured by quantitative PCR, ELISA, and virus neutralization tests. Needle-less, immersion immunizations with test formulations will be assessed in fish for safety and efficacy. Multiple, additional in vivo pathogen challenges will be conducted to evaluate new prototype vaccines for relative efficacy and commercialization potential in Phase III field trials. SUMMARY OF

Anticipated Results:
Effective, immersion anti-viral vaccines could be a major boost to aquaculture sustainability, export market access, and profitability. We anticipate that this new platform technology will provide an economical, non-toxic, “micro-attachment” vaccine delivery system for enhanced infectious disease prevention and control. If successful, these treatments will promote an increased choice of cultured species, greater predictability of production for investment, and a substantial reduction in actual and perceived environmental impact. The growth of environmentally sustainable aquaculture systems will help the United States reduce huge seafood trade deficits (Nash 2004)